MDM2 and cancer: Nutlin, first identified by Vassilev et al., are potential MDM2 inhibitors that can interact with the p53-binding pocket of MDM2, which as a consequence, results in p53 accumulation and p53 -mediated cycle arrest and apoptosis in cancer cells [725].